I-Mab - ADR

NASDAQ:IMAB  
67.29
+0.29 (+0.43%)
Earnings Announcements

I-Mab Reports Financial Results For Full Year Of 2020 And Provides Business Updates

Published: 03/29/2021 11:18 GMT
I-Mab - ADR (IMAB) - I-mab Reports Financial Results for Full Year of 2020 and Provides Business Updates.
I-mab - Total Cash Position of Rmb 4.8 Billion Driven by Hillhouse-led Pipe Financing and Abbvie Licensing Payments Sufficient to Fund Operations Through 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $51.75 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.